Literature DB >> 21302523

[Levels of burden of Alzheimer disease caregivers].

Serena Passoni1, Manuela Mazzà, Gabriele Zanardi, Gabriella Bottini.   

Abstract

INTRODUCTION: Our aim was to investigate the caregiver burden by means of scales to quantify the perceived burden, and the anxiety and depression levels.
METHODS: Seventy-seven caregivers of patients with Alzheimer disease or other kinds of dementia (19 males and 58 females) admitted to the Alzheimer Evaluation Unit of Milan Niguarda Ca'Granda Hospital, were enrolled and filled in Caregiver Burden Inventory (CBI) and the short form of the Anxiety and Depression scale (AD-R). The statistical analysis demonstrates that caregiver with relatives affected by more severe cognitive impairment (patients) show significant levels of burden and anxiety.
RESULTS: The most relevant burden dimensions are: Time-Dependence Burden, Developmental Burden and Physical Burden. Time-Dependence Burden and Social Burden significantly correlate with cognitive (p = 0.01, p = 0.05) and functional rates of patients (p = 0.01, p = 0.05), whereas Developmental Burden only correlates with cognitive rates (p = 0.01). The more prolonged patients' disease the higher the caregivers'anxiety level (p < 0.05). There is nota significant correlation between the Developmental Burden, Physical Burden and Depression, observed in the caregivers' sample, and the cognitive and functional state of patients.
CONCLUSIONS: Alzheimer disease caregivers need an increase of their personal time anda specific intervention aimed to reduce the perceived feeling of social isolation, the physical distress and the anxious and depressive symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 21302523

Source DB:  PubMed          Journal:  G Ital Med Lav Ergon        ISSN: 1592-7830


  3 in total

1.  Depressive symptoms in caregivers of patients with dementia: demographic variables and burden.

Authors:  Pasquale De Fazio; Paola Ciambrone; Gregorio Cerminara; Elvira Barbuto; Antonella Bruni; Patrizia Gentile; Amalia Talarico; Roberto Lacava; Pietro Gareri; Cristina Segura-García
Journal:  Clin Interv Aging       Date:  2015-07-01       Impact factor: 4.458

Review 2.  The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer's disease: a systematic review.

Authors:  Chenxia Sheng; Weijun Peng; Zi-An Xia; Yang Wang; Zeqi Chen; Nanxiang Su; Zhe Wang
Journal:  BMC Complement Altern Med       Date:  2015-10-24       Impact factor: 3.659

3.  Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol (EMDR-IGTP) Applied to Caregivers of Patients With Dementia.

Authors:  Serena Passoni; Teresa Curinga; Alessio Toraldo; Manuela Berlingeri; Isabel Fernandez; Gabriella Bottini
Journal:  Front Psychol       Date:  2018-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.